Eli Lilly has acquired Engage Biologics, a preclinical biotechnology company developing a novel DNA delivery system, for up to $202 million in cash. The pharmaceutical company's financing for the ...

WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), recently hosted its third CRDMO Day in Tokyo, bringing together senior leaders and ...

SEOUL, South Korea, May 18, 2026 /PRNewswire/ -- LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company ...

Engage Bio’s Tethosome platform is designed to improve the potency, tolerability, and redosability of non-viral DNAAcquisition combines Engage’s innovative platform with Lilly’s broad genetic ...

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), ("Scinai" or the "Company") a biopharmaceutical company focused on ...

Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products ...

As biologics have come to supersede small molecules in the biopharma industry’s pipeline, the mounting complexity behind the ...

As the demand for safer, more effective, and naturally derived cosmetic ingredients continues to expand worldwide, industry observers point to the company’s growing role in supplying standardized and ...

HCW11-040 is a pembrolizumab-based fusion immunotherapeutic that activates immune cells and eliminates high-oxygen induced senescent cells BPD is a rare pediatric disease affecting underweight prematu ...

According to the latest market analysis by Future Market Insights (FMI), the global Cell Culture Media Market is projected to grow from USD 3.7 billion ...

A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and ...